Six DMRs located on HOXA9, HOXD3, PCDH17, NID2, NPTX2, and SFRP2 genes exhibiting clinical accuracy over 75% irrespective of lung cancer subtype and cancer progression stages were selected as lung cancer-specific exosome DNA methylation biomarkers. The gene discussed is PCDH17; the disease is lung carcinoma.